| |
Overall survival
|
Cause-specific survival
|
|---|
|
Covariate
|
HR
|
95% CI
|
P-value
|
HR
|
95% CI
|
P-value
|
|---|
|
Age (70:45)
|
2.50
|
1.86-3.35
|
<0.001*
|
2.17
|
1.53-3.08
|
<0.001*
|
|
Sex
| | | | | | |
|
Male
|
1
| | |
1
| | |
|
Female
|
1.13
|
0.81-1.57
|
0.46
|
1.27
|
0.85-1.90
|
0.24
|
|
Race
| | | | | | |
|
White
|
1
| | |
1
| | |
|
Non White
|
1.10
|
0.73-1.64
|
0.66
|
0.86
|
0.51-1.45
|
0.56
|
|
Year of diagnosis (2000:1990)
|
0.82
|
0.65-1.02
|
0.08
|
0.72
|
0.56-0.93
|
0.01*
|
|
Stage
| | | | | | |
|
Localized
|
1
| | |
1
| | |
|
Regional
|
2.38
|
1.52-3.73
|
<0.001*
|
3.99
|
2.04-7.81
|
<0.001*
|
|
Distant
|
3.80
|
2.25-6.41
|
<0.001*
|
6.46
|
3.10-13.50
|
<0.001*
|
|
Histological type
| | | | | | |
|
Squamous cell carcinoma
|
1
| | |
1
| | |
|
Adenocarcinoma
|
0.24
|
0.13-0.44
|
<0.001*
|
0.20
|
0.09-0.45
|
<0.001*
|
|
Others
|
0.34
|
0.23-0.52
|
<0.001*
|
0.31
|
0.18-0.53
|
<0.001*
|
|
Surgery
| | | | | | |
|
No surgery
|
1
| | |
1
| | |
|
Surgery
|
0.59
|
0.40-0.86
|
0.01*
|
0.61
|
0.39-0.96
|
0.03*
|
|
Radiation
| | | | | | |
|
No
|
1
| | |
1
| | |
|
Yes
|
2.51
|
1.75-3.58
|
<0.001*
|
3.55
|
2.22-5.69
|
<0.001*
|
-
Abbreviations: HR Hazard Ratio, CI Confidence Interval.
- *P <0.05.
